9 Analysts Have This to Say About Cogent Biosciences
Portfolio Pulse from Benzinga Insights
In the last quarter, Cogent Biosciences (NASDAQ:COGT) received 7 bullish and 2 somewhat bullish ratings from 9 analysts. The average 12-month price target is $23.44, a 9.85% decrease from the previous average of $26.00.
June 12, 2023 | 7:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cogent Biosciences received mostly bullish ratings from analysts, with an average 12-month price target of $23.44, down 9.85% from the previous target.
The majority of analysts have a bullish or somewhat bullish outlook on Cogent Biosciences, indicating a positive sentiment towards the stock. The average 12-month price target of $23.44, despite being lower than the previous target, still suggests potential growth in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100